Leibrock Robert William sold (to issuer) $55K of ACIW

Leibrock Robert William (Chief Financial Officer) sold (to issuer) 1,289 shares of ACI WORLDWIDE, INC. (ACIW) at $42.80 on 2026-06-06.

Original reporting
SEC EDGAR · Leibrock Robert William
Published Jun 8, 2026, 9:10 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 8, 2026, 9:16 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$ACIW
Neutral
medium confidence
Mentioned
$ACIW
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ACIWNeutralLow
01

Why it matters

Insider selling disclosures can influence short-term sentiment, but this specific “sale to issuer” transaction typically has limited fundamental read-through absent additional company news.

02

Market read

A new SEC Form 4 disclosure for ACIW shows a small insider sale; traders may monitor for follow-on filings but should not treat it as a standalone fundamental catalyst.

03

What to watch

The article provides no context on whether the sale is part of compensation, tax planning, or issuer buyback mechanics beyond the code; without that, signal quality is low.

Relevance 3/10Novelty 6/10Timing: filed 2026-06-08 (covers trade dated 2026-06-06)

Background

The article summarizes an SEC Form 4 insider transaction for ACI WORLDWIDE, Inc. (ACIW).

Company-level read

Ticker impact

$ACIWNeutralMedium confidence
Context

ACIW CFO Robert William Leibrock sold 1,289 shares to the issuer at $42.80/share via SEC Form 4 (sale to issuer).

Expected impact

Low likelihood of a sustained price move; any reaction is likely muted and short-lived.

Evidence & confidence

The filing is a disclosed insider transaction (sale to issuer) with no 10b5-1 plan and no accompanying fundamental catalyst in the text.

Market effects

No sector-level implications; this is company-specific insider transaction disclosure.

None indicated.

None indicated.

Counterpoint

Because the transaction is coded as “sale to issuer,” it may reflect administrative liquidity/plan mechanics rather than a bearish view on ACIW.

Key entities

  • ACIW

    Company whose CFO insider transaction was reported on SEC Form 4.

  • Robert William Leibrock

    Chief Financial Officer who sold shares to the issuer.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$ACIWMedAI 8/10

Needham reiterates Hold on ACI Worldwide stock after Q3 beat

Needham kept a Hold rating on ACI Worldwide (NASDAQ:ACIW) after its Q3 results. Revenue and EBITDA beat expectations but declined year-over-year due to license renewal timing. The company reaffirmed its 2026 revenue outlook and raised EBITDA guidance. Q4 guidance bracketed consensus. Shares are up 38% over six months, trading at $59.52. New annual recurring revenue bookings grew sharply, while license and services bookings declined.

$ACIMed

ACI Worldwide, Inc. Q3 2026 Earnings Call Summary

ACI Worldwide reported a Q3 2026 revenue decline due to timing of license renewals. The company is transitioning to payments orchestration, with ACI Kinetic gaining its first live customer, Solaris, and signing a large African bank. Management is confident in meeting full-year targets, with 95% of revenue already secured. They expect meaningful revenue from Kinetic in 2027 and anticipate long-term growth driven by global payments complexity.

$ACIWMedAI 8/10

ACI Worldwide Misses On EPS As Renewal Timing Guts Q3, But An Accelerating ARR Engine And A Third EBITDA Raise Shift The Burden To Q4

ACI Worldwide (ACIW) reported Q3 EPS of $0.32, missing estimates, with revenue at $426.81M, slightly above consensus. Payment Software revenue dropped 24%, impacting margins. Adjusted EBITDA fell 43% to $98M. However, net new ARR bookings rose 86% and operating cash flow increased 63%. Management raised adjusted EBITDA guidance for the third time. Shares are up 24% from their September low, with Q4 performance critical for meeting full-year targets.